Dark

DTIL
Precision Biosciences Inc
stock NASDAQ

At Close

6/24/2022 3:59:58 PM EDT

1.46USD0.000%(0.00)14,905,036

1.43Bid 1.48Ask 0.05Spread IEX

Pre-market

6/24/2022 9:10:15 AM EDT

1.49USD+2.055%(+0.03)600

After-hours

6/24/2022 4:54:54 PM EDT

1.43USD-1.379%(-0.02)21,827

Overview Option Chain HistoricalMore

open chart

Market Cap

90.778M

Headquarters

Durham, North Carolina, USA

Industry

Biotechnology

Next Earnings

2022-08-09 (44d)

Jan 25, 2022

09:03AM EST Thomson, Ph.D. as Chief Scientific Officer and Two Additional Senior Appointments PR Newswire

Jan 5, 2022

11:07AM EST Stocks That Hit 52-Week Lows On Wednesday Benzinga

Dec 11, 2021

04:46PM EST Precision BioSciences Announced Clinical Program Updates for Its Allogeneic CAR T Pipeline at ASH 2021; Said High Response Rates to PBCAR0191 Observed in Heavily Treated Patients Who Relapsed Following Prior Autologous CAR T Therapy Benzinga

Dec 6, 2021

04:50PM EST Precision BioSciences To Host Webcast, Conference Call On Saturday, Dec. 11, 2021 To Review Interim Phase 1/2a Data For Its CAR-T Cell Candidate Benzinga

06:07AM EST The Week Ahead In Biotech (Dec. 6-Dec. 11): Dar FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More Benzinga

More News

Stats

Avg. Vol. 10 Day

8,731,390

Avg. Vol. 30 Day

3,491,525

Employees

198

Market Cap

90,777,556

Shares Out.

62,176,408

Float

51,013,345

On/Off Exchange

62%/38%

6 Month Beta

2.12

1 Year Beta

1.95

2 Year Beta

1.77

3 Year Beta

1.58

52 Week Low

1.11

52 Week High

14.38

SMA50

1.61

SMA200

4.01

1 Week

+15.87%

1 Month

-6.41%

3 Month

-53.36%

6 Month

-81.80%

1 Year

-87.18%

2 Year

-82.66%

5 Year

-91.63%

Profile

Precision BioSciences, Inc. is a clinical stage biotechnology company dedicated to improving life (DTIL) with its wholly proprietary ARCUS® genome editing platform. ARCUS is a highly specific and versatile genome editing platform that was designed with therapeutic safety, delivery, and control in mind. Using ARCUS, the Company's pipeline consists of multiple 'off-the-shelf' CAR T immunotherapy clinical candidates and several in vivo gene correction therapy candidates to cure genetic and infectious diseases where no adequate treatments exist.

DTIL Stock Summary

Precision Biosciences Inc (NASDAQ:DTIL) stock price today is $1.46, and today's volume is 14,905,036. DTIL is down 0.000% today. The 30 day average volume is 3,491,525. DTIL market cap is 90.778M with 62,176,408 shares outstanding.

.dark-mode .zVXnfZ{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .zVXnfZ{ color: #333333; background-color: white; border: 2px solid #333333; }DTILPrecision Biosciences Incstock NASDAQ

DTIL Stock Summary

DTIL
Precision Biosciences Inc
stock NASDAQ